OAB-049: Impact of baseline ocular conditions (BOCs) on belantamab mafodotin (belamaf)–related corneal events in patients (pts) with relapsed or refractory multiple myeloma (RRMM)
Clinical Lymphoma Myeloma and Leukemia（2022）
关键词
belantamab mafodotin,corneal events,refractory multiple myeloma,baseline ocular conditions,multiple myeloma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要